AMAG Pharmaceuticals to Participate in 15th Annual Needham Healthcare Conference

WALTHAM, Mass., April 06, 2016 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the 15^th Annual Needham Healthcare Conference in New York City. The company is scheduled to present on Wednesday, April 13, 2016 at 12:10 pm ET and will provide a corporate update followed by a question and answer session.

A live webcast of the presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com, and will be archived for 30 days.

About AMAG
AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives. Headquartered in Waltham, MA, AMAG possesses a diverse portfolio of products to support the health of patients in the areas of maternal health, anemia management and cancer supportive care. Through CBR®, the company also helps families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood conditions and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. CBR® is a registered trademark of CBR Systems, Inc.

AMAG Pharmaceuticals Contact: 
Linda Lennox
Vice President, Investor Relations
617-498-2846